|
|
Novel Cancer-Targeted Nanoparticles
| Project funded by own resources |
| Project title |
Novel Cancer-Targeted Nanoparticles |
| Principal Investigator(s) |
Palivan, Cornelia
|
| Co-Investigator(s) |
Benenson, Yaakov
|
| Project Members |
Skowicki, Michal Jerzy
|
| Organisation / Research unit |
Departement Chemie / Physikalische Chemie (Palivan) |
| Project start |
01.01.2019 |
| Probable end |
30.06.2021 |
| Status |
Completed |
| Abstract |
The objective of the project is to facilitate clinical application of the unique drug platform developed by TargImmune Therapeutics, cancer-targeted nanoparticles activating immune system, by better understanding its mode of action as well as thorough characterization of nanoparticle physicochemical properties |
| Financed by |
University funds
|
| |
|
|
MCSS v5.8 PRO. 0.400 sec, queries - 0.000 sec
©Universität Basel | Impressum
|  |
|
26/04/2024
Research Database / FORSCHUNGSDATENBANK
|
